Compare GSK plc (GSK) vs Monolithic Power Systems Inc (MPWR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Monolithic Power Systems Inc — how do they compare? GSK plc trades at $46.5 (market cap $91.88B), while Monolithic Power Systems Inc trades at $1,386.29 (market cap $67.32B). The key difference: GSK plc is the larger of the two by market cap, and GSK plc pays the higher dividend (3.9%). Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and Monolithic Power Systems Inc for 25 Days on average.
| GSK | MPWR | |
|---|---|---|
Market Cap | $91.88B | $67.32B |
Volume | 7,730,529 | 826,960 |
Sector | Health | Technology |
52-Week High | $61.18 | $1.69K |
52-Week Low | $43.24 | $856.96 |
Typical Hold Time | 93 Days | 25 Days |
Enterprise Value | $111.88B | $65.92B |
Dividend Yield | 3.9% | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $46.54, down 1.02% with bearish technical signals but strong fundamentals including 29.73% ROE and consistent earnings beats. The company maintains robust profitability with 72.73% gross margins and is actively expanding its oncology pipeline through strategic partnerships. Recent developments include a $750M cancer therapy acquisition and advancing mRNA vaccine candidates.
GSK presents a mixed outlook with strong operational performance offset by technical weakness. Investment appeal lies in valuation multiples below industry averages and pipeline expansion, though risks include HIV patent expirations and manufacturing restructuring. Analyst consensus leans cautious with 55% hold ratings amid near-term headwinds.
MPWR trades at $1,369.80, down 3.94% today but maintains strong technical momentum with bullish moving averages. The company demonstrates robust fundamentals with 24.5% net income margin and consistent earnings beats, supported by AI infrastructure demand. Recent news highlights CEO stock sales and a strategic manufacturing partnership with GlobalFoundries to expand capacity.
Outlook remains positive with 88% analyst buy ratings and $1,830 consensus price target, though premium valuations (P/E 83.6) and insider selling present near-term risks. Revenue growth to $3.3B in 2026 and expanding AI market opportunities support long-term potential, but investors should monitor execution risks and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Monolithic Power Systems Inc
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →
